Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Characterization of hydroxyl radical modified GAD65: A potential autoantigen in type 1 diabetes

Khan, Mohd Wajid A., Sherwani, Subuhi, Khan, Wajid, Moinuddin and Ali, Rashid 2009. Characterization of hydroxyl radical modified GAD65: A potential autoantigen in type 1 diabetes. Autoimmunity 42 (2) , pp. 150-158.

Full text not available from this repository.


Glutamic acid decarboxylase-65 (GAD65) is an immunological marker of type 1 autoimmune diabetes. High titre of autoantibodies against GAD65 (GAD65Abs) have also been detected in some other autoimmune diseases. In search of a potential immunological marker of type 1 diabetes, in vitro GAD65 was modified by hydroxyl radical followed by the study of structural and conformational perturbed protein by different spectroscopic techniques (UV, fluorescence and CD) and thermal denaturation profile. Binding studies of circulating autoantibodies from diabetic groups (type 1 and type 2) with native and reactive oxygen species (ROS) modified GAD65, exhibited high recognition of type 1 diabetic serum autoantibodies with modified antigen (p < 0.001) over unmodified GAD65. Binding specificity of isolated IgG of patients (n = 17) from each diabetic group and control group (n = 10) was checked by inhibition enzyme linked immunosorbent assay (ELISA) and quantitative precipitin titration assay. Relative affinity of ROS-GAD65Abs for modified and native GAD65 was in the order of 1.56 × 10− 6 and 2.72 × 10− 7 M, as calculated by Langmuir plot. In coherence, ROS oxidation of GAD65 causes conformational perturbation, generating highly immunogenic unique neoepitopes that may be one of the factors in antigen-driven induction of type 1 diabetes autoantibodies that can serve as a potential marker in early diagnosis/prognosis of the disease.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Medicine
Subjects: R Medicine > RC Internal medicine
R Medicine > RM Therapeutics. Pharmacology
Additional Information: Autoantibodies, type 1 diabetes, ROS-GAD65, reactive oxygen species
Publisher: Informa Healthcare
ISSN: 0891-6934
Last Modified: 10 Jun 2022 03:59

Citation Data

Cited 28 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item